1.1 Colorectal Cancer 1.1. 1 The Nature of Colorectal Cancer Colorectal cancer (CRC) is the
third most frequent carcinoma and the second leading cause of cancer-associated death …

Immune response has a crucial role in the control of tumoral progression in colorectal
cancer (CRC). A close link between the rate of tumor infiltrating lymphocytes and prognosis …

3505 Background: Colorectal cancer (CRC) is a molecularly heterogeneous disease that
arises and progresses in the context of a complex microenvironment. Tumor immune cell …

There is growing evidence that both local and systemic inflammatory responses play an
important role in the progression of a variety of solid tumors. Colorectal cancer (CRC) results …

Immunoprofiling is useful for predicting prognosis in various malignancies and provides
targets for immunotherapy. Quantitative multispectral imaging system, which allows …

Sporadic or hereditary colorectal cancer (CRC) with microsatellite instability (MSI) is
frequently characterized by inflammatory lymphocytic infiltration and tends to be associated …

Simple Summary The incidence of non-hereditary cancer in the left colon and rectum is
increasing in young patients worldwide for unknown reasons. To understand this …

Colorectal cancer (CRC) is a major contributor to cancer-related morbidity and mortality,
accounting for approximately one million new cases per year throughout the world, with …

Almost 20 years have passed since the first consensus definition on the immune
characteristics of cancer, which included:(i) the progression of cancer occurs in a …

3620 Background: Colorectal cancer (CRC) is divided into 2 groups based on genomic
differences: chromosomal instability (80%), and microsatellite instability (MSI)(20%). MSI …